China’s shingles vaccine landscape revolutionized as GSK partners with Zhifei
Global pharmaceutical titan GSK plc is teaming up with Chongqing Zhifei Biological Products, Ltd. (Zhifei) – China’s leading vaccine revenue generator – to co-promote its groundbreaking shingles vaccine, Shingrix, across the vast Chinese terrain. This exclusive three-year collaboration, beginning 1 January 2024, is set to be a game-changer in elevating patient access to Shingrix. There’s […]